Zika virus (ZIKV) is a single-stranded RNA virus and mosquito-borne flavivirus. The recent years, Zika virus infection as a re-emerging infection is responsible for the major global health problem. Several routes of ZIKV transmission has been identified; vectors (Aedes mosquitoes) bite, urine, blood, saliva, sexual contact, breast feeding, vertical transmission.Many of studies showed that more than 80% of ZIKV infections are asymptomatic [1]. When symptomatic disease occured its symptoms include fever, headache, cervical lymphadenopathy, maculopapular pruritic rash, arthralgia, myalgia and pain behind the eyes.Moreover, congenital Zika virus infection with and without microcephaly or other central nervous system (CNS) anomalies and Guillain-Barre Syndrome (GBS) are relevant complications of this infection. There are no specific treatment options or vaccine for Zika virus infection.Therefore, the study of the pathogenesis of Zika virus, can help resolve the challenges in treatment and prevention. Despite numerous studies on pathogenesis, many factors involved in infection and immune system response are somewhat unknown.The skin (keratinocyte, langerhans cell, fibroblast) is the primary inoculation site of ZIKV, and then this agent spread to lymph nodes, blood and also CNS, muscles and fetus. Need to